Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // December 23rd, 2009 // 7:29 am
The pace may be slowing down, but the Pharmalot corporate campus remains open for business. And why not? There is always something going on. Of course, many of you will be running off shortly to other activities, but meanwhile, here are a few items to help you stay abreast. And please don’t forget - if you spot something interesting, let us know. Have a good day, everyone…
Bristol-Myers Cuts Outlook After Mead Split (Associated Press)
Novartis Pays $120M For Heart Drug Company (The Street.com)
Pfizer Jury Set Prempro Damages At $8 Million (Bloomberg News)
Shire Files For FDA Approval Of Fabry Disease Drug (PharmaTimes)
Abbott Patent Loss To NYU, Centocor Is Finalized (SouthEast Texas Record)
Tree courtesy of Flickr Creative Commons Jack Duval
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Corthera, Fabry Disease, Novartis, Pfizer, Prempro, Shire Pharmaceuticals